The King is in the altogether: Radiation therapy after oncoplastic breast surgery
Orit Kaidar-Person,
Birgitte Vrou Offersen,
Trine Tramm,
Peer Christiansen,
Tine Engberg Damsgaard,
Ashutosh Kothari,
Philip Poortmans
Affiliations
Orit Kaidar-Person
Breast Radiation Unit, Oncology Institute, Sheba Tel Hashomer, Ramat Gan, Israel; Tel Aviv University, Israel; Corresponding author. Breast Cancer Radiation Therapy Unit, Sheba Medical Center, Ramat Gan, Israel.
Birgitte Vrou Offersen
Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark
Trine Tramm
Department of Pathology, Aarhus University Hospital, and Department of Clinical Medicine, Aarhus University, Denmark
Peer Christiansen
Department of Plastic and Breast Surgery, Aarhus University Hospital, Denmark
Tine Engberg Damsgaard
Department of Plastic Surgery and Burns Treatment, Copenhagen University Hospital, Copenhagen, Denmark
Ashutosh Kothari
Department of Breast Surgery Guy's Hospital London, UK
Philip Poortmans
Department of Radiation Oncology, Iridium Netwerk, Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
Breast cancer is the most common malignancy, and the majority of the patients are diagnosed at an early disease stage. Breast conservation is the preferred locoregional approach, and oncoplastic breast conservation surgery is becoming more popular. This narrative review aims to discuss the challenges and uncertainties in target volume definition for postoperative radiation after these procedures, to improve radiation therapy decisions and encourage multidisciplinary.
